Alzheimer’s Association (2008) 2008 Alzheimer’s disease facts and figures. Alzheimers Dement 4:110–133
Article
Google Scholar
Kivipelto M, Solomon A (2006) Cholesterol as a risk factor for Alzheimer’s disease-epidemiological evidence. Acta Neurol Scand Suppl 185:50–57
PubMed
Article
CAS
Google Scholar
Duron E, Hanon O (2008) Vascular risk factors, cognitive decline, and dementia. Vasc Health Risk Manag 4:363–381
PubMed
CAS
Google Scholar
Carlsson CM, Nondahl DM, Klein BE, McBride PE, Sager MA, Schubert CR et al (2009) Increased atherogenic lipoproteins are associated with cognitive impairment: effects of statins and subclinical atherosclerosis. Alzheimer Dis Assoc Disord 23:11–17
PubMed
Article
CAS
Google Scholar
Tukiainen T, Tynkkynen T, Mäkinen VP, Jylänki P, Kangas A, Hokkanen J et al (2008) A multi-metabolite analysis of serum by 1H NMR spectroscopy: Early systemic signs of Alzheimer’s disease. Biochem Biophys Res Commun 375:356–361
PubMed
Article
CAS
Google Scholar
Reitz C, Tang MX, Manly J, Schupf N, Mayeux R, Luchsinger JA (2008) Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. Dement Geriatr Cogn Disord. 25:232–237
PubMed
Article
CAS
Google Scholar
Ala-Korpela M, Korhonen A, Keisala J, Hörkkö S, Korpi P, Ingman LP et al (1994) 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. J Lipid Res 35:2292–2304
PubMed
CAS
Google Scholar
Ala-Korpela M (2008) Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics. Clin Chem Lab Med 46:27–42
PubMed
Article
CAS
Google Scholar
Hänninen T, Hallikainen M, Tuomainen S, Vanhanen M, Soininen H (2002) Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 106:148–154
PubMed
Article
Google Scholar
Vehtari A, Mäkinen VP, Soininen P, Ingman P, Mäkelä SM, Savolainen MJ et al (2007) A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data. BMC Bioinformatics 8(Suppl2):S8
PubMed
Article
Google Scholar
Mäkinen VP, Soininen P, Forsblom C, Parkkonen M, Ingman P, Kaski K et al (2008) 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol 4:167
PubMed
Article
Google Scholar
Taylor VH, MacQueen GM (2007) Cognitive dysfunction associated with metabolic syndrome. Obes Rev 8:409–418
PubMed
Article
CAS
Google Scholar
Raffaitin C, Gin H, Empana JP, Helmer C, Berr C, Tzourio C et al (2009) Metabolic syndrome and risk for incident Alzheimer’s disease or vascular dementia: the Three-City Study. Diabetes Care 32:169–174
PubMed
Article
Google Scholar
Farr SA, Yamada KA, Butterfield DA, Abdul HM, Xu L, Miller NE et al (2008) Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 149:2628–2636
PubMed
Article
CAS
Google Scholar
Burgess BL, McIsaac SA, Naus KE, Chan JY, Tansley GH, Yang J et al (2006) Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer’s disease mouse models with abundant A beta in plasma. Neurobiol Dis 24:114–127
PubMed
Article
CAS
Google Scholar
Cagnin A, Zambon A, Zarantonello G, Vianello D, Marchiori M, Mercurio D et al (2007) Serum lipoprotein profile and APOE genotype in Alzheimer’s disease. J Neural Transm Suppl 72:175–179
PubMed
Article
CAS
Google Scholar
Kuusisto J, Koivisto K, Mykkänen L, Helkala EL, Vanhanen M, Hänninen T et al (1997) Association between features of the insulin resistance syndrome and Alzheimer’s disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 315:1045–1049
PubMed
Article
CAS
Google Scholar
Mielke MM, Zandi PP, Sjögren M, Gustafson D, Ostling S, Steen B et al (2005) High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64:1689–1695
PubMed
Article
CAS
Google Scholar
Reitz C, Tang MX, Luchsinger J, Mayeux R (2004) Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61:705–714
PubMed
Article
Google Scholar
Solomon A, Kåreholt I, Ngandu T, Winblad B, Nissinen A, Tuomilehto J et al (2007) Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 68:751–756
PubMed
Article
CAS
Google Scholar
Stewart R, White LR, Xue QL, Launer LT (2007) Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 64:103–107
PubMed
Article
Google Scholar
Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K et al (1999) Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 282:254–260
PubMed
Article
CAS
Google Scholar
Yaffe K, Barrett-Connor E, Lin F, Grady D (2002) Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 59:378–384
PubMed
Article
Google Scholar
Mitchell AJ, Shiri-Feshki M (2009) Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand 119:252–265
PubMed
Article
CAS
Google Scholar
Lee KS, Hong CH, Cheong HK, Oh BH (2009) Difference in nutritional risk between mild cognitive impairment group and normal cognitive function elderly group. Arch Gerontol Geriatr 49:49–53
PubMed
Article
Google Scholar